Observational Clinical Study of the Natural Course and Long-term Prognosis of Patients With Chronic Liver Disease

NCT05653830 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50000

Last updated 2022-12-16

No results posted yet for this study

Summary

Chronic liver disease is a global public health problem. Without timely diagnosis and treatment, chronic liver disease can progress to hepatitis, liver fibrosis, and cirrhosis, while causing a variety of complications such as gastrointestinal bleeding, hepatic encephalopathy, hepatorenal syndrome, and liver cancer. Early detection and treatment can slow down the progression of chronic liver disease and reduce the burden of patients. This study intends to construct a retrospective-prospective cohort of patients with chronic liver disease by building a multicenter collaborative network to study the disease characteristics, progression patterns, clinical features, natural course and long-term prognosis of chronic liver disease of different etiologies.

Conditions

Sponsors & Collaborators

  • Ankang Central Hospital

    collaborator OTHER
  • 3201 Hospital in Hanzhong

    collaborator OTHER
  • Weinan Central Hospital

    collaborator OTHER
  • Second Affiliated Hospital of Xi'an Jiaotong University

    collaborator OTHER
  • Tang-Du Hospital

    collaborator OTHER
  • First Affiliated Hospital of Xinjiang Medical University

    collaborator OTHER
  • General Hospital of Ningxia Medical University

    collaborator OTHER
  • Lanzhou University Second Hospital

    collaborator OTHER
  • First Affiliated Hospital of Lanzhou University

    collaborator UNKNOWN
  • The Fourth People's Hospital of Qinghai Province

    collaborator OTHER
  • Yan'an University Affiliated Hospital

    collaborator OTHER
  • First Affiliated Hospital Xi'an Jiaotong University

    lead OTHER

Principal Investigators

  • Yingli He · First Affiliated Hospital Xi'an Jiaotong University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2024-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05653830 on ClinicalTrials.gov